307 related articles for article (PubMed ID: 11086283)
1. [Azole resistance in Candida albicans].
Perea S
Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
4. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance genes and trailing growth in Candida albicans isolates.
Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
[TBL] [Abstract][Full Text] [Related]
6. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Perea S; López-Ribot JL; Wickes BL; Kirkpatrick WR; Dib OP; Bachmann SP; Keller SM; Martinez M; Patterson TF
Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
[TBL] [Abstract][Full Text] [Related]
9. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.
Goldman GH; da Silva Ferreira ME; dos Reis Marques E; Savoldi M; Perlin D; Park S; Godoy Martinez PC; Goldman MH; Colombo AL
Diagn Microbiol Infect Dis; 2004 Sep; 50(1):25-32. PubMed ID: 15380275
[TBL] [Abstract][Full Text] [Related]
11. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
12. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
Li X; Brown N; Chau AS; López-Ribot JL; Ruesga MT; Quindos G; Mendrick CA; Hare RS; Loebenberg D; DiDomenico B; McNicholas PM
J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086
[TBL] [Abstract][Full Text] [Related]
13. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans.
Morio F; Pagniez F; Besse M; Gay-andrieu F; Miegeville M; Le Pape P
Int J Antimicrob Agents; 2013 Nov; 42(5):410-5. PubMed ID: 24051054
[TBL] [Abstract][Full Text] [Related]
14. Resistant mechanisms of Candida albicans to fluconazole.
Wang W; Li R; Wang D; Li S; Zhu L; Wang X; Wan Z; Zhai W
Chin Med J (Engl); 1999 May; 112(5):466-71. PubMed ID: 11593521
[TBL] [Abstract][Full Text] [Related]
15. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
Flowers SA; Colón B; Whaley SG; Schuler MA; Rogers PD
Antimicrob Agents Chemother; 2015 Jan; 59(1):450-60. PubMed ID: 25385095
[TBL] [Abstract][Full Text] [Related]
16. Azole susceptibility and resistance in Candida dubliniensis.
Pinjon E; Moran GP; Coleman DC; Sullivan DJ
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
[TBL] [Abstract][Full Text] [Related]
17. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.
Chau AS; Mendrick CA; Sabatelli FJ; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Jun; 48(6):2124-31. PubMed ID: 15155210
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
19. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Rautemaa R; Richardson M; Pfaller M; Koukila-Kähkölä P; Perheentupa J; Saxén H
J Antimicrob Chemother; 2007 Oct; 60(4):889-92. PubMed ID: 17704513
[TBL] [Abstract][Full Text] [Related]
20. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]